Mint balance
Mint sensory direction; 20-pouch tin. A GABA-led compatibility prototype, with fill mass and mouthfeel assessed first. Final ingredients and strengths remain subject to feasibility and market review.
Deep Relaxation pouches
An evening-oriented concept brief exploring sensory experience and ingredient compatibility, without a promise of sedation or treatment.
Your development starting point
An evening-oriented concept brief exploring sensory experience and ingredient compatibility, without a promise of sedation or treatment.
Ingredient direction
GABA + glycine + a chamomile direction
Flavor flexibility
Mint, berry, citrus, peach or a restrained neutral sensory study.
Pack flexibility
16- or 20-pouch tins and an individual barrier-pack assessment.
Project support
OEM, ODM, CRO and CDMO scopes can be quoted for this concept.
Specifications to agree
| Decision | Development position |
|---|---|
| Ingredient amount | Not fixed. Determine ingredient form, daily intake, safety and market eligibility before a dose is selected. |
| Fill weight | Set after payload and sensory feasibility; ingredient amount and total pouch mass are different. |
| Pouch dimensions | Proposed common direction: 2 × 3 cm; maximum proposed direction: 2 × 4 cm. |
| Pack count | 16 or 20 pouches per tin; individual moisture-barrier sachets can be assessed. |
| Onset and duration | Not established for this concept. No fixed or fast-acting effect is promised. |
| Shelf life | Assigned only after a stability program supports the formula and final packaging. |
| MOQ and lead time | Quoted per project, ingredient supply, pack format, testing and SKU count. |
| Development targets | Nicotine-free scope; sugar-free / plant-based options subject to composition review. |
Two formula review routes
Baseline assessment
A GABA-led compatibility prototype, with fill mass and mouthfeel assessed first.
Extended assessment
A glycine and chamomile combination reviewed for payload, allergen information, taste and market status.
The concept name describes a brand direction, not a clinically established effect. Neither fast relief nor freedom from drowsiness or dependence is assumed.
Six configurable briefs
Berry direction
Berry sensory direction; 16-pouch tin. A GABA-led compatibility prototype, with fill mass and mouthfeel assessed first. Final ingredients and strengths remain subject to feasibility and market review.
Citrus profile
Citrus sensory direction; 20-pouch tin. A GABA-led compatibility prototype, with fill mass and mouthfeel assessed first. Final ingredients and strengths remain subject to feasibility and market review.
Peach profile
Peach sensory direction; 16-pouch tin. A glycine and chamomile combination reviewed for payload, allergen information, taste and market status. Final ingredients and strengths remain subject to feasibility and market review.
Botanical simplicity
Restrained botanical sensory direction; individual barrier sachet. A glycine and chamomile combination reviewed for payload, allergen information, taste and market status. Final ingredients and strengths remain subject to feasibility and market review.
Neutral sensory study
Low-aroma sensory direction; tin + barrier-pack study. A glycine and chamomile combination reviewed for payload, allergen information, taste and market status. Final ingredients and strengths remain subject to feasibility and market review.
Market and evidence review
For US projects, review the product category, ingredient eligibility, label and intended claims with the responsible importer and qualified adviser. For EU projects, check each destination country, ingredient status and permitted claims. Australia and New Zealand require separate classification and ingredient review; a decision for one market does not cover the other.
No public concept page confirms a product authorization or a manufacturing certificate. Ask for the applicable manufacturer records and the evidence needed for the finished specification. Generic ingredient literature does not establish buccal or sublingual absorption, onset or efficacy of this pouch.
Concept questions
Is Deep Relaxation a finished product?
No. It is a configurable development direction. The six briefs help define a sample request, while formula, amounts, warnings, manufacturing scope and destination-market eligibility remain subject to review.
Can this direction be produced under my brand?
OEM, ODM, CRO and CDMO project scopes are available for assessment. The exact responsibilities, sampling costs, commercial terms, intellectual property and release criteria are agreed before work begins.
What claims can I use?
The concept name describes a brand direction, not a clinically established effect. Neither fast relief nor freedom from drowsiness or dependence is assumed. Claims need a separate legal and evidence review for the intended market.
Can I order a sample?
Use the concept form below or the sample enquiry page. Sample scope, fees, shipping and the test plan are agreed first; an enquiry is not an order or payment.
Request this concept
Tell us your destination market, ingredient direction and packaging needs. The team can then assess the scope, sampling route and documentation to quote.